Kaival Brands Announces Pricing of $8.0 Million Underwritten Public Offering of Common Stock and Warrants
Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) announced a public offering of 4,700,000 shares of common stock priced at $1.70 each, alongside warrants for an additional 3,525,000 shares. The offering aims to raise approximately $8.0 million for working capital and corporate purposes. The warrants are set at an exercise price of $1.90, expiring in five years. Underwriters have a 45-day option for additional shares to cover over-allotments. This offering is compliant with a prior SEC registration, and all shares and warrants offered are from the company.
- Expected gross proceeds of approximately $8.0 million to support working capital and corporate initiatives.
- Warrants provide potential future capital at $1.90 per share, encouraging investor engagement.
- Dilution of existing shareholders due to the issuance of new shares and warrants.
- Market reactions may negatively impact stock performance following the public offering.
GRANT, Fla., Sept. 29, 2021 /PRNewswire/ -- Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) ("Kaival Brands"), the exclusive global distributor of products manufactured by Bidi Vapor, LLC ("Bidi Vapor"), today announced the pricing of its underwritten public offering of 4,700,000 shares of its common stock and accompanying warrants to purchase up to 3,525,000 shares of common stock. Each share of common stock was sold together with 0.75 warrants at a combined public offering price of
Kaival Brands currently intends to use the net proceeds from the offering for working capital and general corporate purposes.
Maxim Group LLC is acting as sole book-running manager for the offering.
The public offering is being made pursuant to an effective shelf registration statement on Form S-3 (File No. 333-258339), previously filed with the U.S. Securities and Exchange Commission (SEC) on July 30, 2021 and declared effective on August 10, 2021. The securities may be offered only by means of a prospectus. A preliminary prospectus supplement describing the terms of the public offering has been filed with the SEC. A final prospectus supplement will be filed with the SEC and will form a part of the effective registration statement. Copies of the final prospectus supplement and accompanying prospectus relating to the public offering may be obtained, when available, by contacting Maxim Group LLC, at 300 Park Avenue, 16th Floor, New York, NY 10022, Attention: Syndicate Department, or by telephone at (212) 895-3745 or by email at syndicate@maximgrp.com.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
About Kaival Brands Innovations Group, Inc.
Based in Grant, Florida, Kaival Brands is a company focused on growing and incubating innovative and profitable products into mature and dominant brands in their respective markets. Our vision is to develop internally, acquire, own, or exclusively distribute these innovative products and grow each into dominant market-share brands with superior quality and recognizable innovation. Kaival Brands is the exclusive global distributor of all products manufactured by Bidi Vapor.
Forward Looking Statements
This press release includes statements that constitute "forward-looking statements" within the meaning of federal securities laws, which are statements other than historical facts that frequently use words such as "anticipate," "believe," "continue," "could," "estimate," "expect," "forecast," "intend," "may," "plan," "position," "should," "strategy," "target," "will," and similar words. All forward-looking statements speak only as of the date of this press release. Although we believe that the plans, intentions, and expectations reflected in or suggested by the forward-looking statements are reasonable, there is no assurance that these plans, intentions, or expectations will be achieved. Therefore, actual outcomes and results could materially differ from what is expressed, implied, or forecasted in such statements. Our business may be influenced by many factors that are difficult to predict, involve uncertainties that may materially affect results, and are often beyond our control. Factors that could cause or contribute to such differences include, but are not limited to, the success of the offering of common stock and warrants and the terms thereof; the timing and results of the FDA's PMTA process; the scope of future FDA enforcement of regulations in the ENDS industry; the FDA's approach to the regulation of synthetic nicotine and its impact on our business; the duration and scope of the COVID-19 pandemic and impact on the demand for the products we distribute; the actions governments, businesses, and individuals take in response to the pandemic, including mandatory business closures and restrictions on onsite commercial interactions; the impact of the pandemic and actions taken in response to the pandemic on global and regional economies and economic activity; the pace of recovery when the COVID-19 pandemic subsides; general economic uncertainty in key global markets and a worsening of global economic conditions or low levels of economic growth; the effects of steps that we could take to reduce operating costs; our inability to generate and sustain profitable sales growth; circumstances or developments that may make us unable to implement or realize anticipated benefits, or that may increase the costs, of our current and planned business initiatives; changes in government regulation or laws that affect our business; significant changes in our relationships with our distributors or sub-distributors; and those factors detailed by us in our public filings with the Securities and Exchange Commission. All forward-looking statements included in this press release are expressly qualified in their entirety by such cautionary statements. Except as required under the federal securities laws and the Securities and Exchange Commission's rules and regulations, we do not have any intention or obligation to update any forward-looking statements publicly, whether as a result of new information, future events, or otherwise.
View original content to download multimedia:https://www.prnewswire.com/news-releases/kaival-brands-announces-pricing-of-8-0-million-underwritten-public-offering-of-common-stock-and-warrants-301388379.html
SOURCE Kaival Brands
FAQ
What are the details of Kaival Brands' public offering?
What is the purpose of the funds raised by KAVL's offering?
What are the exercise terms for the warrants issued by Kaival Brands?
How does the public offering impact existing shareholders of KAVL?
What is the ticker symbol for Kaival Brands?
